Niveoli Inhaler

Niveoli Inhaler is a combination inhaler widely used for the management of asthma and chronic obstructive pulmonary disease (COPD). This inhaler provides dual-action therapy, combining the benefits of an anti-inflammatory corticosteroid and a long-acting bronchodilator, offering both symptom control and prevention of asthma attacks.

• Beclometasone (100 MCG) – an inhaled corticosteroid (ICS) that reduces inflammation, swelling, and irritation in the airways, helping prevent asthma flare-ups.

• Formoterol (6 MCG) – a long-acting beta-2 agonist (LABA) that relaxes airway muscles, making breathing easier and improving airflow.

This combination is ideal for patients with moderate to severe asthma who require both maintenance of airway health and quick relief from breathlessness, wheezing, and tightness in the chest. The inhaler is doctor-recommended for long-term asthma control, reducing the frequency of acute episodes and hospital visits.